More and more older Americans want to know their Alzheimer's status, survey finds
A survey of 1,700 Americans 45 and older found that 79% would want to know if they were in the early stages of Alzheimer's disease.
Alzheimer's
An autopsy confirms Gene Hackman died from heart disease
Hackman was also in the advanced stages of Alzheimer's disease and likely had not eaten for a long time, according to the new report. The actor, 95, had been in poor health for some time.
Did a new Alzheimer's drug keep this patient's brain healthier for longer?
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband isn't sure if it made a difference.
Alzheimer's timeline shows changes start as trickle, become torrent
A study of cells from 84 brains finds that Alzheimer's has two distinct phases, and that one type of neuron is especially vulnerable.
In Winston-Salem, youthful guides help navigate the memory loss journeys of their elders
The Intergenerational Center for Arts and Wellness provides a safe and caring environment for up to 1,000 seniors living with dementia each month. Through collaborations with 21 nonprofit partner organizations, coordinators help facilitate meaningful connections between the young and the young at heart.
New blood tests can help diagnose Alzheimer's. Are doctors ready for what's next?
A new generation of blood tests can help diagnose Alzheimer’s disease. But many doctors don’t yet know how to use them.
Medicare explores a new way to support caregivers of dementia patients
The government is launching an experimental program to ease the burden on caregivers of people with Alzheimer's. The idea is to keep patients healthier without exhausting their families.
FDA approves a second Alzheimer's drug that can modestly slow disease
The approval of Eli Lilly's Kisunla provides a new option for patients in the early stages of the incurable, memory-destroying ailment.
FDA approves a second Alzheimer's drug that can modestly slow disease
The approval of Eli Lilly's Kisunla provides a new option for patients in the early stages of the incurable, memory-destroying ailment.
The brain makes a lot of waste. Now scientists think they know where it goes
The brain appears to rely on synchronized waves to wash out waste products, including toxins associated with Alzheimer's disease.